Adar1 Capital Management, LLC Ovid Therapeutics Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 130,532 shares of OVID stock, worth $84,845. This represents 0.02% of its overall portfolio holdings.
Number of Shares
130,532
Previous 37,743
245.84%
Holding current value
$84,845
Previous $44.5 Million
173.66%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$3.46 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.6 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.5 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$2.42 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$2.05 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $45.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...